Todd Roberts, DO
Otolaryngology/Facial Plastic Surgery · Murrieta, CANPI 1962722108
Payments from drug & device makers
What this record shows
Intersect ENT, Inc. accounts for 62.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $1,803 and has fallen 91.4% since, to $156 in 2025.
Across 52 payments — averaging $56.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$2K
- Optinose US, Inc.$348
- Sanofi$177
- Inspire Medical Systems, Inc.$170
- Aerin Medical Inc.$118
- Acclarent, Inc$105
- plus $179 from 5 others
What the payments were for
- Travel & lodging$1,19441%
- Food & beverage$1,74559%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 6 | $1,843 |
| Optinose US, Inc. | 14 | $348 |
| Sanofi | 7 | $177 |
| Inspire Medical Systems, Inc. | 7 | $170 |
| Aerin Medical Inc. | 5 | $118 |
| Acclarent, Inc | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Medtronic | 2 | $41 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| Johnson & Johnson | 1 | $18 |
| GSK | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,938 in reported general payments places this provider in the 70th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 18 | $13,474 |
| Azelastine Hcl | 144 | $3,773 |
| Fluticasone Propionate | 193 | $2,783 |
| Ipratropium Bromide | 54 | $1,348 |
| Ofloxacin | 22 | $544 |
| Azithromycin | 30 | $533 |
| Fluocinolone Acetonide Oil | 11 | $318 |
| Clotrimazole | 15 | $312 |
| Dexamethasone | 15 | $280 |
| Omeprazole | 14 | $199 |
| Cephalexin | 41 | $190 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $171 |
| Doxycycline Hyclate | 12 | $140 |
| Mupirocin | 11 | $96 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $90 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $348 | $13,47418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 102 otolaryngology/facial plastic surgery providers in California.
Other otolaryngology/facial plastic surgery in Murrieta
- Benjamin RobertsMurrieta$856
- Sarmela SunderLancaster$85K
- Vasu DiviStanford$51K
- Jen ChowArcadia$26K
- Ryan CasserlyMonterey$23K
- Ritvik MehtaCarlsbad$13K
- Alexis FurzeNewport Beach$12K
- Jahangir SharifiLos Angeles$12K
- Henry NguyenRancho Cucamonga$11K
- Paul NassifBeverly Hills$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.